These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
728 related articles for article (PubMed ID: 31216433)
21. Anti-hyperglycemic and anti-hyperlipidemic effects of a special fraction of Luohanguo extract on obese T2DM rats. Zhang Y; Zhou G; Peng Y; Wang M; Li X J Ethnopharmacol; 2020 Jan; 247():112273. PubMed ID: 31586692 [TBL] [Abstract][Full Text] [Related]
22. Integrating network analysis and pharmacokinetics to investigate the mechanisms of Danzhi Tiaozhi Decoction in metabolic-associated fatty liver disease (MAFLD). Jiang X; Tang N; Liu Y; Wang Z; Chen J; Liu F; Zhang P; Sui M; Xu W J Ethnopharmacol; 2024 Jan; 318(Pt B):117008. PubMed ID: 37549861 [TBL] [Abstract][Full Text] [Related]
23. Exploring Anti-Type 2 Diabetes Mellitus Mechanism of Gegen Qinlian Decoction by Network Pharmacology and Experimental Validation. Bao W; Sun H; Wu X; Xu J; Zhang H; Cao L; Fan Y Dis Markers; 2022; 2022():1927688. PubMed ID: 36284987 [TBL] [Abstract][Full Text] [Related]
24. Perilla oil regulates intestinal microbiota and alleviates insulin resistance through the PI3K/AKT signaling pathway in type-2 diabetic KKAy mice. Wang J; He Y; Yu D; Jin L; Gong X; Zhang B Food Chem Toxicol; 2020 Jan; 135():110965. PubMed ID: 31743741 [TBL] [Abstract][Full Text] [Related]
25. [Effect of Zuogui Jiangtang Qinggan Formula on lipid metabolism in db/db mouse model of type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease]. Zhou M; Li L; Zou JJ; Liu X; Wu YJ; Xiang Q; Yu R Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1587-1593. PubMed ID: 38621943 [TBL] [Abstract][Full Text] [Related]
26. Ebselen improves lipid metabolism by activating PI3K/Akt and inhibiting TLR4/JNK signaling pathway to alleviate nonalcoholic fatty liver. Pan M; Cai C; Li W; Cao T; Liu Y; Yang L; Xie Q; Zhang X Cytokine; 2024 Sep; 181():156671. PubMed ID: 38943739 [TBL] [Abstract][Full Text] [Related]
27. An herbal formulation "Shugan Xiaozhi decoction" ameliorates methionine/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways. Wang S; Chen B; Du R; Zhong M; Zhang C; Jin X; Cui X; Zhou Y; Kang Q; Xu H; Li Y; Wu Q; Tong G; Luo L J Ethnopharmacol; 2024 Jul; 329():118127. PubMed ID: 38583728 [TBL] [Abstract][Full Text] [Related]
28. Fructus Zanthoxyli extract improves glycolipid metabolism disorder of type 2 diabetes mellitus via activation of AMPK/PI3K/Akt pathway: Network pharmacology and experimental validation. Zhang T; Zhang Q; Zheng W; Tao T; Li RL; Wang LY; Peng W; Wu CJ J Integr Med; 2022 Nov; 20(6):543-560. PubMed ID: 35965234 [TBL] [Abstract][Full Text] [Related]
29. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats. Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586 [TBL] [Abstract][Full Text] [Related]
30. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice. Yang H; Wei D; Zhang Y; Jian W Endocr Metab Immune Disord Drug Targets; 2024; 24(6):691-708. PubMed ID: 37859322 [TBL] [Abstract][Full Text] [Related]
31. The therapeutic mechanism of Yuye decoction on type 2 diabetes mellitus based on network pharmacology and experimental verification. Guo F; Yao L; Zhang W; Chen P; Hao R; Huang X; Jiang J; Wu S J Ethnopharmacol; 2023 May; 308():116222. PubMed ID: 36828194 [TBL] [Abstract][Full Text] [Related]
32. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation. Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y PeerJ; 2022; 10():e14171. PubMed ID: 36389420 [TBL] [Abstract][Full Text] [Related]
33. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats. Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499 [TBL] [Abstract][Full Text] [Related]
34. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways. Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372 [TBL] [Abstract][Full Text] [Related]
35. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease. Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860 [TBL] [Abstract][Full Text] [Related]
36. Effects of Agriophyllum squarrosum extracts on glucose metabolism in KKAy mice and the associated underlying mechanisms. Saqier ; Bao S; Han S; Ao W J Ethnopharmacol; 2019 Sep; 241():112009. PubMed ID: 31158442 [TBL] [Abstract][Full Text] [Related]
37. Exploring the effect and mechanism of Hippophae rhamnoides L. triterpenoid acids on improving NAFLD based on network pharmacology and experimental validation in vivo and in vitro. Ren L; Wang R; Wang Y; Tie F; Dong Q; Wang H; Hu N J Ethnopharmacol; 2024 Dec; 335():118657. PubMed ID: 39127115 [TBL] [Abstract][Full Text] [Related]
38. Exploring therapeutic mechanisms of San-Huang-Tang in nonalcoholic fatty liver disease through network pharmacology and experimental validation. Shi H; Qiao F; Huang K; Lu W; Zhang X; Ke Z; Wu Y; Cao L; Chen Y J Ethnopharmacol; 2022 Oct; 296():115477. PubMed ID: 35764198 [TBL] [Abstract][Full Text] [Related]
39. Effect of Inonotus obliquus (Fr.) Pilat extract on the regulation of glycolipid metabolism via PI3K/Akt and AMPK/ACC pathways in mice. Zhang Z; Liang X; Tong L; Lv Y; Yi H; Gong P; Tian X; Cui Q; Liu T; Zhang L J Ethnopharmacol; 2021 Jun; 273():113963. PubMed ID: 33640441 [TBL] [Abstract][Full Text] [Related]
40. Network pharmacology and molecular docking approaches to elucidate the potential compounds and targets of Saeng-Ji-Hwang-Ko for treatment of type 2 diabetes mellitus. Ko M; Kim Y; Kim HH; Jeong S; Ahn D; Chung SJ; Kim H Comput Biol Med; 2022 Oct; 149():106041. PubMed ID: 36049411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]